Katherine V. Stultz - 10 Apr 2023 Form 4 Insider Report for Kronos Bio, Inc. (KRON)

Role
Director
Signature
/s/ Allison Frisbee, Attorney-in-Fact
Issuer symbol
KRON
Transactions as of
10 Apr 2023
Net transactions value
$0
Form type
4
Filing time
11 Apr 2023, 16:40:51 UTC
Previous filing
24 Jun 2021
Next filing
26 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KRON Director Stock Option (Right to Buy) Award $0 +68,000 $0.000000 68,000 10 Apr 2023 Common Stock 68,000 $1.29 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option shall vest in three equal annual installments following the date of grant.